These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 8150877)

  • 1. Rapid determination of sparteine and its metabolites in urine.
    Veningerová M; Prachar V; Lukácsová M; Glasa J; Holomán J
    J Chromatogr; 1993 Dec; 622(2):274-7. PubMed ID: 8150877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Genetic polymorphism in sparteine oxidation--occurrence in healthy volunteers in Slovakia].
    Holomán J; Glasa J; Veningerová M; Prachar V; Lukácsová M
    Bratisl Lek Listy; 1997 Feb; 98(2):86-90. PubMed ID: 9264814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gas chromatographic determination of sparteine and 2- and 5-dehydrosparteine in plasma and urine.
    Schellens JH; van der Wart HH; Hoevers JW; Breimer DD
    J Chromatogr; 1988 Sep; 431(1):203-9. PubMed ID: 3235532
    [No Abstract]   [Full Text] [Related]  

  • 4. Subnanogram GC/NPD method for the determination of sparteine in biological fluids.
    Kintz P; Tracqui A; Mangin P; Lugnier A; Chaumont A
    Methods Find Exp Clin Pharmacol; 1989 Feb; 11(2):115-8. PubMed ID: 2709917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous determination of sparteine and its 2-dehydro and 5-dehydro metabolites in urine by high-performance liquid chromatography with electrochemical detection.
    Moncrieff J
    J Chromatogr; 1990 Jul; 529(1):194-200. PubMed ID: 2211932
    [No Abstract]   [Full Text] [Related]  

  • 6. A simple borohydride/GC method for measuring sparteine metabolites in man.
    Inaba T; Vinks A; Otton SV
    Br J Clin Pharmacol; 1986 May; 21(5):473-80. PubMed ID: 3718806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gas chromatography/mass spectrometry assays for the determination of debrisoquine and sparteine metabolites in microsomal fractions of rat liver.
    Ho JW; Moody DE
    Anal Biochem; 1992 Jun; 203(2):348-51. PubMed ID: 1416032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sparteine oxidation polymorphism in Greenlanders living in Denmark.
    Brøsen K
    Br J Clin Pharmacol; 1986 Oct; 22(4):415-9. PubMed ID: 3768256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sparteine metabolism in a Nigerian population.
    Ritchie JC; Mitchell SC; Smith RL
    Drug Metabol Drug Interact; 1996; 13(2):129-35. PubMed ID: 8905244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defective N-oxidation of sparteine in man: a new pharmacogenetic defect.
    Eichelbaum M; Spannbrucker N; Steincke B; Dengler HJ
    Eur J Clin Pharmacol; 1979 Sep; 16(3):183-7. PubMed ID: 499318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The polymorphism of pachycarpine oxidation].
    Piotrovskiĭ VK; Belolipetskaia VG; Rumiantsev DO; Metelitsa VI
    Eksp Klin Farmakol; 1992; 55(4):56-8. PubMed ID: 1458193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Further analysis of sparteine oxidation in a Japanese population and comparison with data observed in different ethnic populations.
    Horai Y; Ishizaki T; Eichelbaum M; Hashimoto K; Chiba K; Dengler HJ
    Xenobiotica; 1988 Sep; 18(9):1077-84. PubMed ID: 3227705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of cytochrome P450 2D6-catalyzed sparteine metabolism in humans.
    Ebner T; Meese CO; Eichelbaum M
    Mol Pharmacol; 1995 Dec; 48(6):1078-86. PubMed ID: 8848008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mephenytoin and sparteine oxidation: genetic polymorphisms in Denmark.
    Drøhse A; Bathum L; Brøsen K; Gram LF
    Br J Clin Pharmacol; 1989 May; 27(5):620-5. PubMed ID: 2757884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification of 5-fluorouridine in human urine by capillary gas-liquid chromatography with a nitrogen-selective detector.
    De Leenheer AP; Gelijkens CF
    J Chromatogr Sci; 1978 Nov; 16(11):552-5. PubMed ID: 730817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of site-specified tritium labelling to confirm the formation of 17-oxosparteine as a minor urinary metabolite of sparteine in man.
    Ritchie JC; Mitchell SC; Smith RL; Zhang AQ
    Xenobiotica; 1996 Sep; 26(9):977-82. PubMed ID: 8893044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New evidence of sparteine metabolites in humans.
    Pospísil J; Patzelová V; Máca B
    Drug Metab Dispos; 1992; 20(2):330-2. PubMed ID: 1352230
    [No Abstract]   [Full Text] [Related]  

  • 18. Evidence for polymorphic oxidation of sparteine in Japanese subjects.
    Ishizaki T; Eichelbaum M; Horai Y; Hashimoto K; Chiba K; Dengler HJ
    Br J Clin Pharmacol; 1987 Apr; 23(4):482-5. PubMed ID: 3580254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sparteine metabolism in Canadian Caucasians.
    Vinks A; Inaba T; Otton SV; Kalow W
    Clin Pharmacol Ther; 1982 Jan; 31(1):23-9. PubMed ID: 7053300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous determination of metoprolol and metabolites in urine by capillary column gas chromatography as oxazolidineone and trimethylsilyl derivatives.
    Gyllenhaal O; Hoffmann KJ
    J Chromatogr; 1984 Aug; 309(2):317-28. PubMed ID: 6480783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.